169 related articles for article (PubMed ID: 23904677)
1. Sleep transitions in hypocretin-deficient narcolepsy.
Sorensen GL; Knudsen S; Jennum P
Sleep; 2013 Aug; 36(8):1173-7. PubMed ID: 23904677
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of orexin signaling during sleep is involved in abnormal REM sleep architecture in narcolepsy.
Ito H; Fukatsu N; Rahaman SM; Mukai Y; Izawa S; Ono D; Kilduff TS; Yamanaka A
Proc Natl Acad Sci U S A; 2023 Oct; 120(41):e2301951120. PubMed ID: 37796986
[TBL] [Abstract][Full Text] [Related]
3. Sleep-stage transitions during polysomnographic recordings as diagnostic features of type 1 narcolepsy.
Christensen JA; Carrillo O; Leary EB; Peppard PE; Young T; Sorensen HB; Jennum P; Mignot E
Sleep Med; 2015 Dec; 16(12):1558-66. PubMed ID: 26299470
[TBL] [Abstract][Full Text] [Related]
4. Insufficient non-REM sleep intensity in narcolepsy-cataplexy.
Khatami R; Landolt HP; Achermann P; Rétey JV; Werth E; Mathis J; Bassetti CL
Sleep; 2007 Aug; 30(8):980-9. PubMed ID: 17702267
[TBL] [Abstract][Full Text] [Related]
5. Specificity of direct transition from wake to REM sleep in orexin/ataxin-3 transgenic narcoleptic mice.
Fujiki N; Cheng T; Yoshino F; Nishino S
Exp Neurol; 2009 May; 217(1):46-54. PubMed ID: 19416673
[TBL] [Abstract][Full Text] [Related]
6. Melanin-concentrating hormone neurons contribute to dysregulation of rapid eye movement sleep in narcolepsy.
Naganuma F; Bandaru SS; Absi G; Mahoney CE; Scammell TE; Vetrivelan R
Neurobiol Dis; 2018 Dec; 120():12-20. PubMed ID: 30149182
[TBL] [Abstract][Full Text] [Related]
7. Orexin neurons are necessary for the circadian control of REM sleep.
Kantor S; Mochizuki T; Janisiewicz AM; Clark E; Nishino S; Scammell TE
Sleep; 2009 Sep; 32(9):1127-34. PubMed ID: 19750917
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive detection of sleep/wake changes and cataplexy-like behaviors in orexin/ataxin-3 transgenic narcoleptic mice across the disease onset.
Sato M; Sagawa Y; Hirai N; Sato S; Okuro M; Kumar S; Kanbayashi T; Shimizu T; Sakai N; Nishino S
Exp Neurol; 2014 Nov; 261():744-51. PubMed ID: 25118620
[TBL] [Abstract][Full Text] [Related]
9. A consensus definition of cataplexy in mouse models of narcolepsy.
Scammell TE; Willie JT; Guilleminault C; Siegel JM;
Sleep; 2009 Jan; 32(1):111-6. PubMed ID: 19189786
[TBL] [Abstract][Full Text] [Related]
10. History of narcolepsy at Stanford University.
Mignot EJ
Immunol Res; 2014 May; 58(2-3):315-39. PubMed ID: 24825774
[TBL] [Abstract][Full Text] [Related]
11. A series of 7 cases of patients with narcolepsy with hypocretin deficiency without the HLA DQB1*06:02 allele.
Miano S; Barateau L; De Pieri M; Riccardi S; Thevenin C; Manconi M; Dauvilliers Y
J Clin Sleep Med; 2023 Dec; 19(12):2053-2057. PubMed ID: 37539640
[TBL] [Abstract][Full Text] [Related]
12. Searching for a marker of REM sleep behavior disorder: submentalis muscle EMG amplitude analysis during sleep in patients with narcolepsy/cataplexy.
Ferri R; Franceschini C; Zucconi M; Vandi S; Poli F; Bruni O; Cipolli C; Montagna P; Plazzi G
Sleep; 2008 Oct; 31(10):1409-17. PubMed ID: 18853938
[TBL] [Abstract][Full Text] [Related]
13. Narcolepsy and emotional experience: a review of the literature.
Schiappa C; Scarpelli S; D'Atri A; Gorgoni M; De Gennaro L
Behav Brain Funct; 2018 Dec; 14(1):19. PubMed ID: 30587203
[TBL] [Abstract][Full Text] [Related]
14. Hypocretinergic and non-hypocretinergic projections from the hypothalamus to the REM sleep executive area of the pons.
Torterolo P; Sampogna S; Chase MH
Brain Res; 2013 Jan; 1491():68-77. PubMed ID: 23122879
[TBL] [Abstract][Full Text] [Related]
15. Lucid dreaming in narcolepsy.
Dodet P; Chavez M; Leu-Semenescu S; Golmard JL; Arnulf I
Sleep; 2015 Mar; 38(3):487-97. PubMed ID: 25348131
[TBL] [Abstract][Full Text] [Related]
16. Narcolepsy in African Americans.
Kawai M; O'Hara R; Einen M; Lin L; Mignot E
Sleep; 2015 Nov; 38(11):1673-81. PubMed ID: 26158891
[TBL] [Abstract][Full Text] [Related]
17. Running promotes wakefulness and increases cataplexy in orexin knockout mice.
España RA; McCormack SL; Mochizuki T; Scammell TE
Sleep; 2007 Nov; 30(11):1417-25. PubMed ID: 18041476
[TBL] [Abstract][Full Text] [Related]
18. A vertebrate family without a functional Hypocretin/Orexin arousal system.
Bitsikas V; Cubizolles F; Schier AF
Curr Biol; 2024 Apr; 34(7):1532-1540.e4. PubMed ID: 38490200
[TBL] [Abstract][Full Text] [Related]
19. Modafinil and γ-hydroxybutyrate have sleep state-specific pharmacological actions on hypocretin-1 physiology in a primate model of human sleep.
Zeitzer JM; Buckmaster CL; Landolt HP; Lyons DM; Mignot E
Behav Pharmacol; 2009 Oct; 20(7):643-52. PubMed ID: 19752724
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the efficacy of the hypocretin/orexin receptor agonists TAK-925 and ARN-776 in narcoleptic orexin/tTA; TetO-DTA mice.
Sun Y; Ranjan A; Tisdale R; Ma SC; Park S; Haire M; Heu J; Morairty SR; Wang X; Rosenbaum DM; Williams NS; De Brabander JK; Kilduff TS
J Sleep Res; 2023 Aug; 32(4):e13839. PubMed ID: 36808670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
